Cargando…
Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924827/ https://www.ncbi.nlm.nih.gov/pubmed/36780313 http://dx.doi.org/10.18632/oncotarget.28346 |
| _version_ | 1784887931444396032 |
|---|---|
| author | Marengo, Barbara Meta, Elda Brullo, Chiara Ciucis, Chiara De Colla, Renata Speciale, Andrea Garbarino, Ombretta Bruno, Olga Domenicotti, Cinzia |
| author_facet | Marengo, Barbara Meta, Elda Brullo, Chiara Ciucis, Chiara De Colla, Renata Speciale, Andrea Garbarino, Ombretta Bruno, Olga Domenicotti, Cinzia |
| author_sort | Marengo, Barbara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9924827 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99248272023-02-14 Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma Marengo, Barbara Meta, Elda Brullo, Chiara Ciucis, Chiara De Colla, Renata Speciale, Andrea Garbarino, Ombretta Bruno, Olga Domenicotti, Cinzia Oncotarget Correction Impact Journals LLC 2023-02-11 /pmc/articles/PMC9924827/ /pubmed/36780313 http://dx.doi.org/10.18632/oncotarget.28346 Text en Copyright: © 2023 Marengo et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Marengo, Barbara Meta, Elda Brullo, Chiara Ciucis, Chiara De Colla, Renata Speciale, Andrea Garbarino, Ombretta Bruno, Olga Domenicotti, Cinzia Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| title | Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| title_full | Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| title_fullStr | Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| title_full_unstemmed | Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| title_short | Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| title_sort | correction: biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924827/ https://www.ncbi.nlm.nih.gov/pubmed/36780313 http://dx.doi.org/10.18632/oncotarget.28346 |
| work_keys_str_mv | AT marengobarbara correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT metaelda correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT brullochiara correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT ciucischiarade correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT collarenata correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT specialeandrea correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT garbarinoombretta correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT brunoolga correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma AT domenicotticinzia correctionbiologicalevaluationofpyrazolylureaanddihydroimidazopyrazolylureaderivativesaspotentialantiangiogeneticagentsinthetreatmentofneuroblastoma |